Retasturtide is a recently developed novel GLP-1 receptor agonist demonstrating encouraging results in the treatment of type 2 diabetes. This synthetic peptide duplicates the actions of naturally occurring GLP-1, a https://louisevwqp889314.rimmablog.com/37987391/retasturtide-a-novel-glp-1-receptor-agonist-for-type-2-diabetes